Sequential Kinase Inhibition (Idelalisib/Ibrutinib) Induces Clinical Remission in B-Cell Prolymphocytic Leukemia Harboring a 17p Deletion

Figure 1

Peripheral blood smear. The lymphoid cells are of intermediate to large size with a prominent nucleolus and cytoplasm protrusions (Wright-Giemsa, ×1000).